Literature DB >> 3009197

The role of thyroid scanning in hyperthyroidism.

I Fogelman, S G Cooke, M N Maisey.   

Abstract

Radionuclide thyroid imaging was performed in 872 consecutive patients with hyperthyroidism. Of these, 84% were found to have diffuse toxic hyperplasia (Graves' disease), while 12% had autonomously functioning nodules (Plummer's disease), 3% had Graves' disease developing in a multinodular gland, and in the remaining 1%, either a clear diagnosis could not be established or the hyperthyroidism was due to thyroiditis or the Jod-Basedow phenomenon. It was found that a thyroid scan seldom provides additional diagnostic information in patients with Graves' disease when a diffuse goitre is present. However, if patients are to be treated with radioiodine (131I), thyroid imaging with tracer quantitation can replace a 24-h 131I uptake measurement, this having the advantages that the patients are required to attend only once, and that the gland size can be measured. In addition, visual confirmation of tracer uptake by the thyroid is obtained and patients with thyroiditis will not receive inappropriate therapy. When single or multiple thyroid nodules are palpated, a thyroid scan is crucial in establishing an accurate diagnosis, as it is not otherwise possible to differentiate between Plummer's disease and Graves' disease developing in a multinodular gland. Indeed, in 20 of our 63 patients (32%) with single autonomously functioning nodules, the initial clinical assessment had been incorrect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009197     DOI: 10.1007/bf00261404

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Use of 99 Tc m for the routine assessment of thyroid function.

Authors:  A W Goolden; H I Glass; E D Williams
Journal:  Br Med J       Date:  1971-11-13

2.  Relationship of the thyroid scintiscan to the therapeutic effects of 131I in hyperthyroidism with diffuse goiter.

Authors:  S L Tjoe; B Levine; R G Wieland; J C Chen
Journal:  J Nucl Med       Date:  1971-12       Impact factor: 10.057

3.  Thyroid registers--an indecent obsession?

Authors:  A D Toft
Journal:  Scott Med J       Date:  1983-10       Impact factor: 0.729

4.  Choice of therapy for Graves' hyperthyroidism.

Authors:  D V Becker
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

5.  Hyperthyroidism from the thyroid follicle with autonomous function.

Authors:  J M Miller
Journal:  Clin Endocrinol Metab       Date:  1978-03

Review 6.  Scintigraphic evaluation of nodular goiter.

Authors:  N D Charkes
Journal:  Semin Nucl Med       Date:  1971-07       Impact factor: 4.446

7.  Malignant cold thyroid nodules in hyperthyroidism.

Authors:  D Livadas; A Psarras; D A Koutras
Journal:  Br J Surg       Date:  1976-09       Impact factor: 6.939

8.  Is thyroid scintigraphy necessary before I-131 therapy for hyperthyroidism? Concise communication.

Authors:  S D Ripley; J E Freitas; C E Nagle
Journal:  J Nucl Med       Date:  1984-06       Impact factor: 10.057

9.  Choice of therapy in young adults with hyperthyroidism of Graves' disease. A brief, case-directed poll of fifty-four thyroidologists.

Authors:  J T Dunn
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

Review 10.  Iodide-induced thyrotoxicosis.

Authors:  J E Fradkin; J Wolff
Journal:  Medicine (Baltimore)       Date:  1983-01       Impact factor: 1.889

View more
  4 in total

Review 1.  The role of nuclear medicine in clinical investigation.

Authors:  E M Prvulovich; J B Bomanji
Journal:  BMJ       Date:  1998-04-11

2.  Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake.

Authors:  Hae Won Kim; Byeong-Cheol Ahn; Sang-Woo Lee; Jaetae Lee
Journal:  Thyroid       Date:  2012-04-23       Impact factor: 6.568

3.  The different types of hyperthyroidism in Europe. Results of a prospective survey of 924 patients.

Authors:  D Reinwein; G Benker; M P König; A Pinchera; H Schatz; A Schleusener
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

4.  A remarkable case of thyrotoxicosis initially caused by graves' disease followed by a probable TSHoma - a case report.

Authors:  Mark Quinn; Waiel Bashari; Diarmuid Smith; Mark Gurnell; Amar Agha
Journal:  BMC Endocr Disord       Date:  2020-08-27       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.